This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Rapid Onset of Antidepressant Activity With Venlafaxine

Richard H. Weisler and Susan van Meter

Published: June 18, 2002

Article Abstract

Letter to the Editor

Sir: In their recent article, "How Fast Are Antidepressants?" Drs. Gelenberg and Chesen rightly acknowledged the benefits of novel, fast-acting antidepressants. These benefits include alleviating patient suffering, reducing hospital stay length, and, most importantly, preserving life by decreasing the risk of suicide. The availability of venlafaxine may reduce the severalweek therapeutic delay associated with other available antidepressants.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 63

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...